ReviewMedical oncology (Northwood, London, England)2017

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.

Wiktoria Blaszczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.